Literature DB >> 23531732

68Ga DOTATATE PET/CT uptake in spinal lesions and MRI correlation on a patient with neuroendocrine tumor: potential pitfalls.

Ifigeneia Klinaki1, Adil Al-Nahhas, Neil Soneji, Zarni Win.   

Abstract

A 62-year-old female patient with suspected insulinoma underwent 68Ga DOTA-TATE PET/CT for characterization and staging. This demonstrated a focus of uptake in the pancreas and 3 foci of uptake in the spine. An MRI of the spine performed to further characterize the lesions revealed the presence of a meningioma and degenerative changes, both of which showed 68Ga DOTA-TATE uptake. A vertebral metastasis seen on PET was occult on CT and MRI. A vertebral hemangioma had no discrete tracer uptake. Awareness of sources of error in interpreting 68Ga DOTA-TATE scans is important in order to avoid pitfalls.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23531732     DOI: 10.1097/RLU.0b013e31827a2325

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  9 in total

1.  Positron emission tomographic imaging of copper 64- and gallium 68-labeled chelator conjugates of the somatostatin agonist tyr3-octreotate.

Authors:  Jessie R Nedrow; Alexander G White; Jalpa Modi; Kim Nguyen; Albert J Chang; Carolyn J Anderson
Journal:  Mol Imaging       Date:  2014       Impact factor: 4.488

2.  Vertebral metastases from neuroendocrine tumours: How to avoid false positives on 68Ga-DOTA-TOC PET using CT pattern analysis?

Authors:  Mathieu Gauthé; Nathalie Testart Dardel; Fernando Ruiz Santiago; Jessica Ohnona; Valérie Nataf; Françoise Montravers; Jean-Noël Talbot
Journal:  Eur Radiol       Date:  2018-03-12       Impact factor: 5.315

Review 3.  Principles in the design of ligand-targeted cancer therapeutics and imaging agents.

Authors:  Madduri Srinivasarao; Chris V Galliford; Philip S Low
Journal:  Nat Rev Drug Discov       Date:  2015-02-20       Impact factor: 84.694

Review 4.  Current status and future of targeted peptide receptor radionuclide positron emission tomography imaging and therapy of gastroenteropancreatic-neuroendocrine tumors.

Authors:  Neil Grey; Michael Silosky; Christopher H Lieu; Bennett B Chin
Journal:  World J Gastroenterol       Date:  2022-05-07       Impact factor: 5.374

5.  PET/MRI for neuroendocrine tumors: a match made in heaven or just another hype?

Authors:  Ali Pirasteh; Christopher Riedl; Marius Erik Mayerhoefer; Romina Grazia Giancipoli; Steven Mark Larson; Lisa Bodei
Journal:  Clin Transl Imaging       Date:  2019-09-20

Review 6.  Imaging of neuroendocrine tumors: A pictorial review of the clinical value of different imaging modalities.

Authors:  Ali Pirasteh; Petra Lovrec; Lisa Bodei
Journal:  Rev Endocr Metab Disord       Date:  2021-03-30       Impact factor: 9.306

7.  An international expert opinion statement on the utility of PET/MR for imaging of skeletal metastases.

Authors:  Jad S Husseini; Bárbara Juarez Amorim; Angel Torrado-Carvajal; Vinay Prabhu; David Groshar; Lale Umutlu; Ken Herrmann; Lina García Cañamaque; José Ramón García Garzón; William E Palmer; Pedram Heidari; Tiffany Ting-Fang Shih; Jacob Sosna; Cristina Matushita; Juliano Cerci; Marcelo Queiroz; Valdair Francisco Muglia; Marcello H Nogueira-Barbosa; Ronald J H Borra; Thomas C Kwee; Andor W J M Glaudemans; Laura Evangelista; Marco Salvatore; Alberto Cuocolo; Andrea Soricelli; Christian Herold; Andrea Laghi; Marius Mayerhoefer; Umar Mahmood; Ciprian Catana; Heike E Daldrup-Link; Bruce Rosen; Onofrio A Catalano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-22       Impact factor: 9.236

8.  (68)Ga-DOTATATE-positron emission tomography imaging in spinal meningioma.

Authors:  Philipp Jörg Slotty; Florian Friedrich Behrendt; Karl-Josef Langen; Jan Frederick Cornelius
Journal:  J Craniovertebr Junction Spine       Date:  2014-01

9.  An Incidental Solitary Plasmacytoma of Bone Mimicking Neuroendocrine Tumor Metastasis on 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography.

Authors:  Duygu Has Şimşek; Serkan Kuyumcu; Bilge Bilgiç; Emine Göknur Işık; Cüneyt Türkmen; Işık Adalet
Journal:  Mol Imaging Radionucl Ther       Date:  2016-10-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.